Meeting Banner
Abstract #4440

TBM and DTI reveal structural changes by memantine treatment in YAC128 mouse model of Huntington disease

Xin Hong1, Marta Garcia-Miralles2, Ling Yun Yeow1, Xuan Vinh To1, Benjamin Chaik Meng Yeo1, Fiftarina Puspitasari1, Katrianne Bethia Koh2, Liang Juin Tan2, Mahmoud Abdul Pouladi2,3, and Kai-Hsiang Chuang1

1Singapore Bioimaging Consortium, Agency for Science, Technology and Research, Singapore, Singapore, 2Translational Laboratory in Genetic Medicine, Agency for Science, Technology and Research, Singapore, Singapore, 3Department of Medicine, National University of Singapore, Singapore, Singapore

T2 weighted structural and diffusion MRI together with behavioral tests were conducted to evaluate the effects of memantine treatment in YAC128 mouse model of Huntington disease. In low-dose (2 mg/kg)-treated YAC128 mice, cognitive functions improved, and increased fractional anisotropy was found in major fiber tracts including the corpus callosum, anterior commissure, and internal capsule. No significant gray matter volume change was detected in treatment groups, though the relative caudate putamen volume showed increasing trend with dose. Our results suggest that low dose memantine treatment had protective effects on white matter in YAC128 mice.

This abstract and the presentation materials are available to members only; a login is required.

Join Here